"Ohio is increasingly competitive in attracting larger, well-known life science brands, plus our institutions continue to spin out new biotech companies; people across the country are starting to notice."
"Continuous manufacturing is key to our US strategy, differentiating us in the market."
"Better alignment between institutions and industry can drive innovation, scientific progress, and economic growth in the coming years."
"Investors are finding it difficult to balance early-phase success with the commercialization hurdles ahead."